To meet this clinical need for safer antithrombotic drugs, the Group focuses on studying protein targets modulated by natural antiplatelet agents found in healthy diets, with a view to identify safer protein targets that could open a pathway to improved treatments for thrombosis.
In this research, the team found that an isothiocyanate derived from cruciferous vegetables like broccoli and kale suppresses thrombogenic platelet activation without causing adverse bleeding effects. The team also identified the protein responsible for these characteristics.